Margaret L. Weaver

883 total citations
12 papers, 257 citations indexed

About

Margaret L. Weaver is a scholar working on Pharmacology, Oncology and Pharmaceutical Science. According to data from OpenAlex, Margaret L. Weaver has authored 12 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Oncology and 3 papers in Pharmaceutical Science. Recurrent topics in Margaret L. Weaver's work include Plant-based Medicinal Research (3 papers), Drug Solubulity and Delivery Systems (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Margaret L. Weaver is often cited by papers focused on Plant-based Medicinal Research (3 papers), Drug Solubulity and Delivery Systems (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Margaret L. Weaver collaborates with scholars based in United States, Switzerland and United Kingdom. Margaret L. Weaver's co-authors include Jefferson Chin, James B. Mangold, Michael J. Shapiro, James F. McLeod, Lolita C. Rodriguez, J.M. Tanzer, Paul A. Kramer, Dennis Ruff, Michael Looby and Christiane Rordorf and has published in prestigious journals such as Journal of Controlled Release, Antimicrobial Agents and Chemotherapy and Pharmaceutical Research.

In The Last Decade

Margaret L. Weaver

10 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margaret L. Weaver United States 9 77 50 48 42 41 12 257
Leslie A. Geer United States 9 142 1.8× 18 0.4× 93 1.9× 25 0.6× 32 0.8× 10 345
Richard DeAngelis United States 10 55 0.7× 76 1.5× 95 2.0× 36 0.9× 58 1.4× 22 395
Katarzyna Kosicka Poland 11 36 0.5× 22 0.4× 21 0.4× 44 1.0× 82 2.0× 28 365
Chung Y. Lui United States 11 42 0.5× 23 0.5× 44 0.9× 77 1.8× 63 1.5× 14 334
Kamal M. Matar Kuwait 12 161 2.1× 34 0.7× 34 0.7× 43 1.0× 38 0.9× 41 436
Ravinder Earla United States 13 32 0.4× 99 2.0× 32 0.7× 50 1.2× 162 4.0× 18 516
Ruediger Nave Japan 15 41 0.5× 16 0.3× 43 0.9× 26 0.6× 42 1.0× 20 806
Robert Guttendorf United States 11 84 1.1× 20 0.4× 34 0.7× 32 0.8× 140 3.4× 27 353
Marc Vermeir Belgium 11 72 0.9× 8 0.2× 80 1.7× 66 1.6× 101 2.5× 17 402

Countries citing papers authored by Margaret L. Weaver

Since Specialization
Citations

This map shows the geographic impact of Margaret L. Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret L. Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret L. Weaver more than expected).

Fields of papers citing papers by Margaret L. Weaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret L. Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret L. Weaver. The network helps show where Margaret L. Weaver may publish in the future.

Co-authorship network of co-authors of Margaret L. Weaver

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret L. Weaver. A scholar is included among the top collaborators of Margaret L. Weaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret L. Weaver. Margaret L. Weaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zheng, Weijia, et al.. (2016). Importance of early characterization of physicochemical properties in developing high-dose intravenous infusion regimens for poorly water-soluble compounds.. PubMed. 64(6). 517–26.
2.
Galarneau, Jean-René, Emily K. Meseck, Robert L. Hall, Wenkui Li, & Margaret L. Weaver. (2016). Naphthoquine-induced Central Nervous System and Hepatic Vasculocentric Toxicity in the Beagle Dog. Toxicologic Pathology. 44(8). 1128–1136.
3.
Weaver, Margaret L., Joanna L. Parish, Ingrid Brück Bøgh, et al.. (2015). Vehicle Systems and Excipients Used in Minipig Drug Development Studies. Toxicologic Pathology. 44(3). 367–372. 9 indexed citations
4.
Nzila, Alexis, Matthias Rottmann, P. Chitnumsub, et al.. (2010). Preclinical Evaluation of the Antifolate QN254, 5-Chloro-N′6′-(2,5-Dimethoxy-Benzyl)-Quinazoline-2,4,6-Triamine, as an Antimalarial Drug Candidate. Antimicrobial Agents and Chemotherapy. 54(6). 2603–2610. 19 indexed citations
5.
Chen, Yen‐Liang, Zheng Yin, Suresh B. Lakshminarayana, et al.. (2010). Inhibition of Dengue Virus by an Ester Prodrug of an Adenosine Analog. Antimicrobial Agents and Chemotherapy. 54(8). 3255–3261. 45 indexed citations
6.
Scott, Graham, Christiane Rordorf, Christine Reynolds, et al.. (2004). Pharmacokinetics of Lumiracoxib in Plasma and Synovial Fluid. Clinical Pharmacokinetics. 43(7). 467–478. 55 indexed citations
7.
Royce, Alan E., Shoufeng Li, Margaret L. Weaver, & Uday Shah. (2004). In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2′-O-methyladenosine. Journal of Controlled Release. 97(1). 79–90. 18 indexed citations
8.
Weaver, Margaret L., Lolita C. Rodriguez, Jefferson Chin, et al.. (2001). Pharmacokinetics and metabolism of nateglinide in humans.. PubMed. 29(4 Pt 1). 415–21. 76 indexed citations
9.
Karara, Adel H., Reginald F. Frye, Peggy E. Hayes, et al.. (1996). Pharmacokinetics of abecarnil in patients with renal insufficiency*. Clinical Pharmacology & Therapeutics. 59(5). 520–528. 5 indexed citations
10.
Nickerson, David F., Margaret L. Weaver, & Francis L. S. Tse. (1994). The effect of oral dose volume on the absorption of a highly and a poorly water soluble drug in the rat. Biopharmaceutics & Drug Disposition. 15(5). 419–429. 9 indexed citations
11.
Weaver, Margaret L., J.M. Tanzer, & Paul A. Kramer. (1992). Pilocarpine Disposition and Salivary Flow Responses Following Intravenous Administration to Dogs. Pharmaceutical Research. 9(8). 1064–1069. 13 indexed citations
12.
Weaver, Margaret L., J.M. Tanzer, & Paul A. Kramer. (1992). High-performance liquid chromatographic determination of pilocarpine in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 581(2). 293–296. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie A. Geer Breakdown of academic impact, for papers by Richard DeAngelis Breakdown of academic impact, for papers by Katarzyna Kosicka Breakdown of academic impact, for papers by Chung Y. Lui Breakdown of academic impact, for papers by Kamal M. Matar Breakdown of academic impact, for papers by Ravinder Earla Breakdown of academic impact, for papers by Ruediger Nave Breakdown of academic impact, for papers by Robert Guttendorf Breakdown of academic impact, for papers by Marc Vermeir
Rankless by CCL
2026